Merck applauds VA for adopting biosimilar medicines to treat veteransMerck’s Renflexis (infliximab-abda) — a biosimilar of Remicade — will be placed on the Department of Veterans Affairs' national formulary. Lupin gets tentative FDA nod for generic Latuda tabletsLupin has received tentative FDA approval for generic Latuda, which has a market value of about $3.1 billion. ANI launches authorized Brethine generic ANI Pharmaceuticals is launching an authorized generic version of Brethine tablets, which has a market value of about $11 million. Glenmark gets FDA green light for generic Westcort cream Glenmark has received the FDA's nod for generic Westcort Cream, which had a market value of about $17 million. Dr. Reddy’s gets FDA nod for generic Aggrenox Dr. Reddy's has received the green light for a generic version of Aggrenox, which has a market value of about $183 million. Camber launches generic Mepron Camber Pharmaceuticals is offering atovaquone oral solution, the generic version of Mepron. FDA kicks off new efforts to advance complex generics The FDA today announced guidance documents to advance the development of generic transdermal and topical delivery systems. Dr. Reddy's launches generic Welchol Dr. Reddy's is unveiling a generic version of Daiichi Sankyo's Welchol tablets, which had a market value of about $471 million. Lupin intros generic Temovate ointment Lupin is launching the generic version of Fougera's temovate ointment, which has a market value of about $93.4 million. Breckenridge gets FDA approval for generic Daliresp for COPD Breckenridge Pharmaceutical has received the Food and Drug Administration's nod for generic Daliresp tablets, which had a market value of $211 million. First Previous 209 210 211 212 213 Next Last
